Company: ANTX
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0000950170-25-052852
Chunk: 32

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 32
---
 | 60,000(1)         |     | 30,000(2)      |

(1) The options vest in 48 monthly increments commencing on the one-month anniversary of the vesting commencement date of January 1, 2024, subject to continued service to the Company through each such vesting date. (2) The RSUs vest in four annual increments commencing on the one-year anniversary of the vesting commencement date of January 1, 2024, subject to continued service to the Company through each such vesting date. (3) The RSUs vest with respect to 25% of the underlying shares vesting on January 1, 2025 and 50% of the underlying shares vesting on January 1, 2026, with the remaining 25% of the underlying shares vesting on July 1, 2026, subject to continued service to the Company through each such vesting date. (4) The options vest in 48 monthly increments commencing on the one-month anniversary of the vesting commencement date of November 4, 2024, subject to continued service to the Company through each such vesting date. (5) The RSUs vest in four annual increments commencing on the one-year anniversary of the vesting commencement date of November 4, 2024, subject to continued service to the Company through each such vesting date. The option grants and stock awards are set forth in the “Outstanding Equity Awards as of December 31, 2024” table below. Named Executive Officer Employment Arrangements Eric Easom We entered into an employment offer letter with Mr. Easom, our President, Chief Executive Officer and Board chair, on November 19, 2019, which sets forth Mr. Easom’s initial base salary, annual bonus opportunity, and eligibility to participate in the Company’s benefit plans. The employment offer letter has no specific term and provides that Mr. Easom is an at-will employee. Josh Eizen We entered into an employment offer letter with Joshua Eizen, our Chief Legal Officer and Chief Operating Officer, on September 22, 2022, which sets forth Mr. Eizen’s initial base salary, annual bonus opportunity, initial stock option grant, and eligibility to participate in the Company’s benefit plans. The employment offer letter has no specific term and provides that Mr. Eizen is an at-will employee. Lucy Day We entered into an employment offer letter with Ms